Terms: = Skin cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Prognosis
5 results:
1. The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis.
Hoesl C; Fröhlich T; Posch C; Kneitz H; Goebeler M; Schneider MR; Dahlhoff M
Mol Oncol; 2021 Aug; 15(8):2140-2155. PubMed ID: 33786987
[TBL] [Abstract] [Full Text] [Related]
2. Predictive genetic profiles for regional lymph node metastasis in primary cutaneous melanoma: a case-matched pilot study.
Nye A; Collins JD; Porter CL; Montes de Oca M; George K; Stafford CG; Schammel CMG; Horton S; Trocha SD
Melanoma Res; 2018 Dec; 28(6):555-561. PubMed ID: 30179987
[TBL] [Abstract] [Full Text] [Related]
3. Expressions and clinical significance of her4 and CD44 in sinonasal mucosal malignant melanoma.
Zhu W; Li S; Zou B; Liu H; Wang S
Melanoma Res; 2018 Apr; 28(2):105-110. PubMed ID: 29309357
[TBL] [Abstract] [Full Text] [Related]
4. Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing erbb4, EPO-R and NGF-R.
Mirkina I; Hadzijusufovic E; Krepler C; Mikula M; Mechtcheriakova D; Strommer S; Stella A; Jensen-Jarolim E; Höller C; Wacheck V; Pehamberger H; Valent P
PLoS One; 2014; 9(1):e84417. PubMed ID: 24489649
[TBL] [Abstract] [Full Text] [Related]
5. Oncogenes in melanoma: an update.
Kunz M
Eur J Cell Biol; 2014; 93(1-2):1-10. PubMed ID: 24468268
[TBL] [Abstract] [Full Text] [Related]
